{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:49:22Z","timestamp":1777718962456,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.radcr.2022.03.109","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T11:34:09Z","timestamp":1652096049000},"page":"2460-2463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual phase 18F-FP CIT PET and 99mTc- ECD SPECT findings of Huntington's disease"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-4340","authenticated-orcid":false,"given":"KyungAh","family":"Chun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radcr.2022.03.109_bib0001","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.radcr.2022.03.109_bib0002","first-page":"779","article-title":"Huntington\u2019 disease\u2013imbalance of amino acid levels in plasma of patients and mutation carriers","volume":"20","author":"Gruber","year":"2013","journal-title":"Ann Agric Environ Med Actions"},{"issue":"9","key":"10.1016\/j.radcr.2022.03.109_bib0003","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.parkreldis.2013.05.005","article-title":"Nigral involvement and nigrostriatal dysfunction in Huntington\u2019s disease: evidences from an MRI and SPECT study","volume":"19","author":"Kiferle","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1016\/j.radcr.2022.03.109_bib0004","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington's disease","volume":"43","author":"Pagano","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.radcr.2022.03.109_bib0005","first-page":"1274","article-title":"Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington\u2019s disease","volume":"34","author":"Ichise","year":"1993","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.radcr.2022.03.109_bib0006","first-page":"384","article-title":"Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis","volume":"47","author":"Van Laere","year":"2006","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.radcr.2022.03.109_bib0007","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.clineuro.2010.07.014","article-title":"Does reduced [(123)I]-FP-CIT binding in Huntington\u2019s disease suggest pre-synaptic dopaminergic involvement?","volume":"112","author":"Gamez","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.radcr.2022.03.109_bib0008","first-page":"360","article-title":"Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET\/CT in patients with parkinsonism","volume":"8","author":"Hong","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radcr.2022.03.109_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2011.06025.x","article-title":"PET\/CT in diagnosis of movement disorders","volume":"1228","author":"Berti","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.radcr.2022.03.109_bib0010","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/RLU.0000000000001474","article-title":"Additional value of early-phase 18F-FP-CIT PET image for differential diagnosis of atypical Parkinsonism","volume":"42","author":"Jin","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.109_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13139-012-0182-4","article-title":"Differential diagnosis of parkinsonism using dual-phase F-18 FP-CIT PET imaging","volume":"47","author":"Jin","year":"2013","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.109_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0001-2998(05)80076-5","article-title":"The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans","volume":"21","author":"Nagel","year":"1991","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1016\/j.radcr.2022.03.109_bib0013","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/jnnp.55.11.1018","article-title":"Reduced regional cerebral blood flow in Huntington\u2019s disease studied by SPECT","volume":"55","author":"Hasselbalch","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043322002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043322002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:57:49Z","timestamp":1761825469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043322002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1930043322002813"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2022.03.109","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual phase 18F-FP CIT PET and 99mTc- ECD SPECT findings of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2022.03.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}